Merck Presses Fed. Circ. To Reopen Nasonex Battle
Merck & Co. Inc. pushed a Federal Circuit panel Tuesday to revive its lawsuit against Apotex Inc. for creating a generic version of its Nasonex nasal spray, alleging the lower court...To view the full article, register now.
Already a subscriber? Click here to view full article